It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Analyzing heart rate variability (HRV) in preterm infants can help track maturational changes and subclinical signatures of disease. We conducted an observational study to characterize the effect of demographic and cardiorespiratory factors on three features of HRV using a linear mixed-effects model. HRV-features were tailored to capture the unique physiology of preterm infants, including the contribution of transient pathophysiological heart rate (HR) decelerations. Infants were analyzed during stable periods in the incubator and subsequent sessions of Kangaroo care (KC) – an intervention that increases comfort. In total, 957 periods in the incubator and during KC were analyzed from 66 preterm infants. Our primary finding was that gestational age (GA) and postmenstrual age (PMA) have the largest influence on HRV while the HR and breathing rate have a considerably smaller effect. Birth weight and gender do not affect HRV. We identified that with increasing GA and PMA, overall HRV decreased and increased respectively. Potentially these differences can be attributed to distinct trajectories of intra- and extrauterine development. With increasing GA, the propensity towards severe HR decelerations decreases, thereby reducing overall variability, while with increasing PMA, the ratio of decelerations and accelerations approaches unity, increasing overall HRV.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Eindhoven University of Technology, Department of Industrial Design, Eindhoven, The Netherlands (GRID:grid.6852.9) (ISNI:0000 0004 0398 8763); Máxima Medical Centre Veldhoven, Department of Clinical Physics, Veldhoven, The Netherlands (GRID:grid.414711.6) (ISNI:0000 0004 0477 4812); Philips Research, Department of Family Care Solutions, Eindhoven, The Netherlands (GRID:grid.417284.c) (ISNI:0000 0004 0398 9387)
2 Máxima Medical Centre, Department of Neonatology, Veldhoven, The Netherlands (GRID:grid.414711.6) (ISNI:0000 0004 0477 4812); Eindhoven University of Technology, Department of Applied Physics, Eindhoven, The Netherlands (GRID:grid.6852.9) (ISNI:0000 0004 0398 8763)
3 Eindhoven University of Technology, Department of Electrical Engineering, Eindhoven, The Netherlands (GRID:grid.6852.9) (ISNI:0000 0004 0398 8763)
4 Consultants in Quantitative Methods, CQM BV, Eindhoven, Netherlands (GRID:grid.6852.9)
5 Eindhoven University of Technology, Department of Industrial Design, Eindhoven, The Netherlands (GRID:grid.6852.9) (ISNI:0000 0004 0398 8763)
6 Máxima Medical Centre Veldhoven, Department of Clinical Physics, Veldhoven, The Netherlands (GRID:grid.414711.6) (ISNI:0000 0004 0477 4812); Eindhoven University of Technology, Department of Applied Physics, Eindhoven, The Netherlands (GRID:grid.6852.9) (ISNI:0000 0004 0398 8763)
7 Máxima Medical Centre, Department of Neonatology, Veldhoven, The Netherlands (GRID:grid.414711.6) (ISNI:0000 0004 0477 4812)




